Lorela Ciraku

604 total citations
9 papers, 455 citations indexed

About

Lorela Ciraku is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Lorela Ciraku has authored 9 papers receiving a total of 455 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Cancer Research and 2 papers in Genetics. Recurrent topics in Lorela Ciraku's work include Glycosylation and Glycoproteins Research (4 papers), RNA modifications and cancer (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Lorela Ciraku is often cited by papers focused on Glycosylation and Glycoproteins Research (4 papers), RNA modifications and cancer (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Lorela Ciraku collaborates with scholars based in United States and China. Lorela Ciraku's co-authors include Mauricio J. Reginato, Neha M. Akella, Zachary A. Bacigalupa, Giang Lê Minh, Valerie L. Sodi, Dimpi Mukhopadhyay, Dennis B. Leeper, Flemming Forsberg, Patrick O’Kane and Ji‐Bin Liu and has published in prestigious journals such as Oncogene, The FASEB Journal and Frontiers in Pharmacology.

In The Last Decade

Lorela Ciraku

9 papers receiving 452 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lorela Ciraku United States 7 341 141 115 64 61 9 455
Neha M. Akella United States 6 294 0.9× 111 0.8× 125 1.1× 48 0.8× 54 0.9× 7 394
Carmen Oi Ning Leung Hong Kong 9 265 0.8× 97 0.7× 52 0.5× 55 0.9× 88 1.4× 17 405
Francesca Ricciardiello Italy 9 283 0.8× 135 1.0× 68 0.6× 50 0.8× 66 1.1× 10 387
Mailin Li United States 9 188 0.6× 81 0.6× 92 0.8× 26 0.4× 57 0.9× 12 335
Yunkyung Heo South Korea 7 239 0.7× 203 1.4× 45 0.4× 44 0.7× 58 1.0× 13 420
Andrea López United States 6 447 1.3× 97 0.7× 66 0.6× 22 0.3× 97 1.6× 10 607
Meng Cao China 11 340 1.0× 148 1.0× 36 0.3× 32 0.5× 57 0.9× 27 449
Tzu-Tang Wei Taiwan 11 307 0.9× 104 0.7× 102 0.9× 27 0.4× 188 3.1× 20 491
Erica Pranzini Italy 14 373 1.1× 262 1.9× 61 0.5× 20 0.3× 107 1.8× 31 577

Countries citing papers authored by Lorela Ciraku

Since Specialization
Citations

This map shows the geographic impact of Lorela Ciraku's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorela Ciraku with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorela Ciraku more than expected).

Fields of papers citing papers by Lorela Ciraku

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lorela Ciraku. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorela Ciraku. The network helps show where Lorela Ciraku may publish in the future.

Co-authorship network of co-authors of Lorela Ciraku

This figure shows the co-authorship network connecting the top 25 collaborators of Lorela Ciraku. A scholar is included among the top collaborators of Lorela Ciraku based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lorela Ciraku. Lorela Ciraku is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Ciraku, Lorela, Adel A. Rashad, Simon Cocklin, et al.. (2024). Selective and brain-penetrant ACSS2 inhibitors target breast cancer brain metastatic cells. Frontiers in Pharmacology. 15. 1394685–1394685. 13 indexed citations
2.
Ciraku, Lorela, Zachary A. Bacigalupa, Jing Ju, et al.. (2022). O-GlcNAc transferase regulates glioblastoma acetate metabolism via regulation of CDK5-dependent ACSS2 phosphorylation. Oncogene. 41(14). 2122–2136. 42 indexed citations
3.
Ciraku, Lorela, et al.. (2022). OGT/CDK5/ACSS2 Axis Regulates Breast Cancer Brain Metastasis Growth. The FASEB Journal. 36(S1). 1 indexed citations
4.
Ciraku, Lorela, et al.. (2021). An <em>Ex Vivo</em> Brain Slice Model to Study and Target Breast Cancer Brain Metastatic Tumor Growth. Journal of Visualized Experiments. 6 indexed citations
5.
Ciraku, Lorela, et al.. (2021). O-GlcNAcylation regulation of cellular signaling in cancer. Cellular Signalling. 90. 110201–110201. 36 indexed citations
6.
Ciraku, Lorela, et al.. (2021). An <em>Ex Vivo</em> Brain Slice Model to Study and Target Breast Cancer Brain Metastatic Tumor Growth. Journal of Visualized Experiments. 1 indexed citations
7.
Akella, Neha M., Giang Lê Minh, Lorela Ciraku, et al.. (2020). O-GlcNAc Transferase Regulates Cancer Stem–like Potential of Breast Cancer Cells. Molecular Cancer Research. 18(4). 585–598. 48 indexed citations
8.
Akella, Neha M., Lorela Ciraku, & Mauricio J. Reginato. (2019). Fueling the fire: emerging role of the hexosamine biosynthetic pathway in cancer. BMC Biology. 17(1). 52–52. 275 indexed citations
9.
Delaney, Lauren J., Lorela Ciraku, Brian E. Oeffinger, et al.. (2019). Breast Cancer Brain Metastasis Response to Radiation After Microbubble Oxygen Delivery in a Murine Model. Journal of Ultrasound in Medicine. 38(12). 3221–3228. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026